Johnson & Johnson (JNJ)

158.46
NYSE
Prev Close 162.76
Day Low/High 157.97 / 162.41
52 Wk Low/High 109.16 / 173.65
Exchange NYSE
Shares Outstanding 2628.68B
Market Cap 427.84B
P/E Ratio 28.74
Div & Yield N.A. (N.A)
Broad Rally, Vaccine Optimism, Johnson & Johnson, GameStop Roars, Trading Nvidia

Broad Rally, Vaccine Optimism, Johnson & Johnson, GameStop Roars, Trading Nvidia

The market's catalyst had everything to do with the virus... optimism that humankind might stuff that scourge back into Pandora's box.

The Suppressed Economy, Impressive Earnings, U.S. Treasury Curve, Pandemic Watch

The Suppressed Economy, Impressive Earnings, U.S. Treasury Curve, Pandemic Watch

I want you to think about how quickly the long end of the U.S. Treasury curve is moving.

Here's Why I'm All in on the 'Normalization' Trade

Here's Why I'm All in on the 'Normalization' Trade

No matter what you want to call it -- there are plenty of reasons to be bullish right now.

Short Story Ends, Watching Curves, Enter J&J, Flexible FDA, Ford Impresses

Short Story Ends, Watching Curves, Enter J&J, Flexible FDA, Ford Impresses

Plus, Thursday was a solid day for nearly all sectors of the market, though Peloton Interactive pulls back after posting results.

Markets Focused on Relief Package, Price Is No Longer Truth, 'Unhedged Funds'

Markets Focused on Relief Package, Price Is No Longer Truth, 'Unhedged Funds'

Let's not kid ourselves that there is any longer some kind of relationship between price and value. Or fact and truth.

Johnson & Johnson Rates Higher Price Targets Based on Its Charts

Johnson & Johnson Rates Higher Price Targets Based on Its Charts

Buyers of the healthcare giant's shares have been more aggressive as the company pushes to launch its own Covid-19 vaccine.

Underperforming Transports, Vaccine Delivery, FOMC Statement, 3 Trading Thoughts

Underperforming Transports, Vaccine Delivery, FOMC Statement, 3 Trading Thoughts

Wednesday afternoon the Fed's Federal Open Market Committee will publish the central bank's first official policy statement of 2021.

Keep Your Eyes on the Speculation Sideshow

Keep Your Eyes on the Speculation Sideshow

I can't say when the market's B-movie will matter, but here's what I can tell you based on the indicators.

Whoa Baby! Here's How I'm Trading Johnson & Johnson After Earnings

Whoa Baby! Here's How I'm Trading Johnson & Johnson After Earnings

The revenue and earnings beats are nice but that's not what really got me fired up.

Could Johnson & Johnson Go Higher and Higher?

Could Johnson & Johnson Go Higher and Higher?

Will the vaccine will be a game changer? The charts are giving indications that J&J is ready to run.

Youth Gone Wild, The Swarm of Individual Traders, GameStop, Melvin Capital

Youth Gone Wild, The Swarm of Individual Traders, GameStop, Melvin Capital

As a trader who at times takes short positions, I don't know whether to stand up and applaud this group or to fear them.

Jim Cramer: This Is a Market of Stocks, Not a Stock Market

Jim Cramer: This Is a Market of Stocks, Not a Stock Market

With few exceptions, there isn't a stock that could bring down this market.

General Electric Isn't Out of the Woods Yet, Here's How I'd Trade it

General Electric Isn't Out of the Woods Yet, Here's How I'd Trade it

GE remains a cash flow based story, but I see two negatives.

Volatile Road Ahead, 4 Market Impact Thoughts, Monster Earnings Week

Volatile Road Ahead, 4 Market Impact Thoughts, Monster Earnings Week

What can be done? Well for one, we are going to have to be creative. Jay, and Janet, I need you both paying attention here.

A Johnson & Johnson Play Ahead of Earnings

A Johnson & Johnson Play Ahead of Earnings

These calls are a real value with earnings coming up.

Jim Cramer: The Market Now Acts Like a Market of Stocks Than a Bushel or a Peck

Jim Cramer: The Market Now Acts Like a Market of Stocks Than a Bushel or a Peck

There was a period before the time of commoditization where individual elan and corporate dominance meant something. And that's back.

Wednesday's Woe, Biden's Plan, U.S. Dollar, J&J Vaccine, Trading Intel

Wednesday's Woe, Biden's Plan, U.S. Dollar, J&J Vaccine, Trading Intel

We are going to live again. You will dance in the aisle at some concert whose performer I have never heard of, and you will cheer for your favorite team in person again.

Jim Cramer: If Government Gets Its Act Together, This Is What Could Happen

Jim Cramer: If Government Gets Its Act Together, This Is What Could Happen

The vaccine rollout has been bungled and the nation's in crisis, but you can either dwell on the negativity or look to ingenuity and opportunity. Here's where I see the latter.

Market Themes, Yield Spreads, Treasury Auction, JNJ Vaccine, Trading Medtronic

Market Themes, Yield Spreads, Treasury Auction, JNJ Vaccine, Trading Medtronic

If all goes well, JNJ could be able to immunize a billion individuals this year just by themselves.

How to Play Emergent BioSolutions Right Now

How to Play Emergent BioSolutions Right Now

A correction in EBS could soon set up an attractive opportunity.

The Week That Was, Q4 Earnings Expectations, Key Investor and Healthcare Events

The Week That Was, Q4 Earnings Expectations, Key Investor and Healthcare Events

This Friday several banks begin the unofficial kickoff of 'earnings season'.

Jim Cramer: Let's See What's Really Sustainable

Jim Cramer: Let's See What's Really Sustainable

As we move through Georgia and see an end in sight to Covid, we need a gut check on what stocks are really going to go the distance.

Jim Cramer: 10 Investment Themes I Like in 2021

Jim Cramer: 10 Investment Themes I Like in 2021

I am talking about themes that can stand the test not of today, or tomorrow, but for all of 2021 and beyond.

Jim Cramer: Here's My Plan to Distribute the Vaccine

Jim Cramer: Here's My Plan to Distribute the Vaccine

We have to take both the private sector and the states out of the equation, and adopt the process that wiped out Polio.

No More Tears: Johnson & Johnson Breaks Out

No More Tears: Johnson & Johnson Breaks Out

This is the time and the place to go long JNJ.

Assessing AstraZeneca in the Fight Against the Virus

Assessing AstraZeneca in the Fight Against the Virus

While there are certainly some things to like about AZN, I don't think this vaccine, nor the UK emergency authorization, make it investable.

I've Come Around to Thinking of Boeing as an Investment

I've Come Around to Thinking of Boeing as an Investment

I think BA returns to normal as we do, as the airlines do... but with the defense contracting business as a foundation to rely upon.

Broad Rally, Tipping the Scales, What to Expect From the Fed, Trading Apple

Broad Rally, Tipping the Scales, What to Expect From the Fed, Trading Apple

The Russell 2000 is now up 7% for December, twice the increase for the Nasdaq Composite.

Jim Cramer: The Christmas Horse Race Begins

Jim Cramer: The Christmas Horse Race Begins

We have bets coming from all directions, and holiday joy abounds as the wagerers move up their stocks with their buying. Let's see how this could play out.

How I'm Playing Astra-Zeneca on Vaccine and Acquisition News

How I'm Playing Astra-Zeneca on Vaccine and Acquisition News

I am staying away from this name for now, despite the Alexion acquisition and vaccine promise.